Edition:
United Kingdom

Grifols SA (GRLSbn.MC)

GRLSbn.MC on Madrid SE C.A.T.S.

16.68EUR
17 May 2019
Change (% chg)

€0.14 (+0.85%)
Prev Close
€16.54
Open
€16.40
Day's High
€16.70
Day's Low
€16.40
Volume
68,091
Avg. Vol
115,066
52-wk High
€21.30
52-wk Low
€15.60

About

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma... (more)

Overall

Beta: 0.53
Market Cap(Mil.): €15,167.80
Shares Outstanding(Mil.): 687.55
Dividend: 0.14
Yield (%): 1.29

Financials

  GRLSbn.MC Industry Sector
P/E (TTM): 29.70 29.30 32.55
EPS (TTM): 0.82 -- --
ROI: 5.94 14.23 13.82
ROE: 16.00 15.46 15.24

Spain's Grifols, China's Shanghai RAAS form strategic alliance

Spanish blood products company Grifols said on Thursday it has signed a strategic alliance with Shanghai RAAS as it looks to increase its sales of plasma-derived products in China.

07 Mar 2019

Spain's Grifols, China's Shanghai RAAS form strategic alliance

March 7 Spanish blood products company Grifols said on Thursday it has signed a strategic alliance with Shanghai RAAS as it looks to increase its sales of plasma-derived products in China.

07 Mar 2019

Earnings vs. Estimates